Pro Doc Limitée voluntarily recalls two lots of irbesartan drugs because of nitrosamine impurity
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69328a-eng.php
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5372775
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5372451
Note de Presse (Hôpital Universitaire la Paix)
TECENTRIQ (atezolizumab) – Risk of Immune-Related Myositis
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69274a-eng.php
Riociguat en el tratamiento de hipertensión pulmonar/Riociguat for the treatment of pulmonary hypertension
http://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.981695
Nivolumab para el tratamiento del cáncer de pulmón de células no pequeñas/Nivolumab for the treatment of non-small cell lung cancer
http://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.981698
Nivolumab en el tratamiento de melanoma avanzado/Nivolumab in advanced melanoma treament
http://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.981702
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5369676
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5369414
